Close×

Coca-Cola Turkey is making use of thermochromic inks on a range of interactive cans provided by Crown.

Both colour and function have been added to 10 new aluminium beverage can designs through the use of thermochromic ink technology as a "true decorative tool", according to the company. 

Four separate inks have been used to create bright designs that stand out when the cans are chilled and the drinks are ready for consumption.

The designs featured on Coke Red and Coke Zero beverage cans all have summer themes, ranging from ice cubes and palm trees to sandals and sailing boats.

“Crown worked with dedication to facilitate the complex printing process of the four inks, a novelty in our line of work,” Matt Twiss, marketing and business development director at Crown Bevcan Europe & Middle East, said.

“While we have used thermochromic ink technology for many commercial applications, the Coca-Cola campaign highlights its potential as a decorative tool, conveying a message of freshness and fun in an aesthetically pleasing and original way. The inks also encourage consumers to interact with the brand at the point of sale and during consumption.”

The cans are produced at Crown’s Osmaniye plant, in central southern Turkey, a production facility with the capacity to produce approximately two billion cans per year.

A total of 70 million units will be produced in 2018 for this campaign alone, with a large number already in the retail supply chain.

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.